banner
JAK inhibitor Cerdulatinib, Purity ≥98%
Inquiry

Cat. No.: X23-10-ZQ366

JAK inhibitor Cerdulatinib, Purity ≥98%

Synonym: 1369761-01-2; Cerdulatinib hydrochloride; Cerdulatinib HCl; Cerdulatinib HCl salt; RVT-502 hydrochloride; Cerdulatinib (hydrochloride); JAK inhibitor

  • CAS Number: 1369761-01-2
  • Compound CID: 56960607
img
Product Size
10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
Cerdulatinib, soluble in warmed DMSO and insoluble in water and ethanol, is an available JAK small molecule inhibitor with potential antineoplastic activity. It targets ARK5, MST1, AMPK, Chk1, FLT3, FLT4, Fms, GCK, ITK, JAK1, and JAK2.
Molecular Weight
482
Molecular Formula
C20H28ClN7O3S
Targets
ARK5: 4 nM; MST1: 4 nM; AMPK: 6 nM; Chk1: 42 nM; FLT3: 90 nM; FLT4: 51 nM; Fms: 5 nM; GCK: 18 nM; ITK: 194 nM; JAK1: 12 nM; JAK2: 6 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
Warmed DMSO: 42 mg/mL (87.14 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Applications
Cerdulatinib is used to investigate the dual inhibition of JAK and SYK kinases in the treatment of hematologic malignancies.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0